Quotient Limited (NASDAQ:QTNT) released its quarterly earnings results on Monday, October 30th. The company reported ($0.58) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.59) by $0.01, Bloomberg Earnings reports. The business had revenue of $5.91 million during the quarter, compared to the consensus estimate of $5.30 million. Quotient Limited had a negative return on equity of 13,050.41% and a negative net margin of 404.29%.
Quotient Limited (NASDAQ QTNT) opened at $4.34 on Wednesday. Quotient Limited has a 52 week low of $3.22 and a 52 week high of $7.74. The company has a debt-to-equity ratio of -5.17, a quick ratio of 0.86 and a current ratio of 1.36.
In related news, insider D J. Paul E. Cowan sold 45,540 shares of the business’s stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $3.52, for a total transaction of $160,300.80. Following the transaction, the insider now directly owns 26,666 shares of the company’s stock, valued at approximately $93,864.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider D J. Paul E. Cowan sold 30,197 shares of the business’s stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $4.92, for a total value of $148,569.24. Following the transaction, the insider now directly owns 26,666 shares in the company, valued at $131,196.72. The disclosure for this sale can be found here. Insiders sold a total of 375,197 shares of company stock worth $1,639,728 over the last ninety days. Corporate insiders own 29.00% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the business. The Manufacturers Life Insurance Company acquired a new position in shares of Quotient Limited in the 2nd quarter valued at approximately $177,000. California State Teachers Retirement System acquired a new position in shares of Quotient Limited in the 2nd quarter valued at approximately $349,000. Vanguard Group Inc. acquired a new position in shares of Quotient Limited in the 2nd quarter valued at approximately $523,000. Finally, State Street Corp acquired a new position in shares of Quotient Limited in the 2nd quarter valued at approximately $1,728,000. 47.85% of the stock is currently owned by institutional investors.
QTNT has been the subject of a number of recent research reports. BTIG Research reiterated a “buy” rating and set a $12.00 price objective on shares of Quotient Limited in a research report on Thursday, August 31st. Jefferies Group LLC dropped their price objective on Quotient Limited from $15.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, November 1st. Zacks Investment Research upgraded Quotient Limited from a “sell” rating to a “hold” rating in a report on Tuesday, October 10th. Finally, ValuEngine cut Quotient Limited from a “sell” rating to a “strong sell” rating in a report on Friday, September 1st.
Quotient Limited Company Profile
Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market.
Receive News & Ratings for Quotient Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient Limited and related companies with MarketBeat.com's FREE daily email newsletter.